MiMedx
Price & Volume
Stats
See more52W Range | $3.03-$7.97 |
Market Cap | $622.3M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $355.1M |
Revenue Growth (YoY) | -34.7% |
Gross Profit (12 Mos) | $280M |
Diluted EPS | $0.04 |
News
See moreYahoo Finance • 9 days ago
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)
Yahoo Finance • 15 days ago
MIMEDX Announces Second Quarter 2026 Operating & Financial Results
Yahoo Finance • 3 months ago
Mimedx expects $260M-$290M 2026 net sales amid $40M cost cuts and wound care reimbursement disruption
Yahoo Finance • 4 months ago
Northland Reaffirms Outperform Rating for MiMedx Group (MDXG)
About
CEO | Mr. Joseph H. Capper |
Address | 1775 West Oak Commons Court, NE, Marietta, GA, United States, 30062 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 808 |